Decreased or altered expression of the FHIT gene in human leukemias

Stem Cells

Volumn 15, Issue 3, 1997, Pages 223-228

  Sugimoto, Koichi ^a   Yamada, Konagi ^b   Miyagawa, Kiyoshi ^b   Hirai, Hisamaru ^b   Oshimi, Kazuo ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b NONE

Author keywords

Ap4A asymmetrical hydrolase; Exon skipping; FHIT gene; Inducible fragile site; Leukemia; RT PCR; Tumor suppressor gene

Indexed keywords

MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 0031010237     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150223     Document Type: Article

References (18)

1. Ohta M, Inoue H, Cotticelli MG et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-597.
2. Kastury K, Baffa R, Druck T et al. Potential gastrointestinal tumor suppressor locus at 3p14.2 FRA3B site identified by homologous deletions in tumor cell lines. Cancer Res 1996;56:978-983.
3. Wilke CM, Hall BK, Hoge A et al. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 1996;5:187-195.
4. Negrini M, Monaco C, Vorechovsky I et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 1996;56:3173-3179.
5. Sozzi G, Veronese ML, Negrini M et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
6. Thiagalingam S, Lisitsyn NA, Hamaguchi M et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996;56:2936-2939.
7. 4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. Biochem J 1995;312:925-932.
8. Baker JC, Jacobson MK. Alteration of adenyl dinucleotide metabolism by environmental stress. Proc Natl Acad Sci USA 1986;83:2350-2352.
9. Baker JC, Ames BN. Alterations in levels of 5′-adenyl dinucleotides following DNA damage in normal human fibroblasts and fibroblasts derived from patients with xeroderma pigmentosum. Mutat Res 1988;208:87-93.
10. Weinmann-Dorsch C, Hedl A, Grummt I et al. Drastic rise of intracellular adenosine(5′)tetraphospho(5′)adenosine correlates with onset of DNA synthesis in eukaryotic cells. Eur J Biochem 1984;138:179-185.
11. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-141.
12. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994;84:4038-4044.
13. Ogawa S, Hangaishi A, Miyawaki S et al. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 1995;86:1548-1556.
14. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994;84:2412-2421.
15. Sugimoto K, Toyoshima H, Sakai R et al. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 1992;79:2378-2383.
16. Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990;10:5502-5509.
17. Farrell PJ, Allan GJ, Shanahan F et al. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J 1991;10:2879-2887.
18. 4A binding protein by photoaffinity labeling. Biochemistry 1994;33:14601-14607.